# Northwest Biotherapeutics Inc: filings

NWBO · OTC · CIK 1072379 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nwbo.md) · [Financials](/companies/nwbo/financials.md) · [Filings](/companies/nwbo/filings.md) · [Insiders](/companies/nwbo/insiders.md)

## Reports and events: 313 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 187, 4 57, 10-Q 53, 424B5 46, UPLOAD 24, CORRESP 22, SC 13G/A 22, 10-K 18, NT 10-Q 18, 10-Q/A 15, DEF 14A 13, NT 10-K 13, SC 13G 12, 10-K/A 10, EFFECT 10, S-3 6, S-3/A 6, 3 5, 4/A 5, D 5, PRE 14A 5, S-1/A 5, 8-K/A 4, SC 13D/A 4, 424B3 3, DEFA14A 3, PRER14A 3, S-1 3, CERTNAS 2, CT ORDER 2, DEF 14C 2, POS AM 2, PRE 14C 2, 25 1, 424B4 1, 5 1, 8-A12B 1, 8-A12B/A 1, 8-A12G/A 1, D/A 1, DEFR14A 1, FWP 1, PRER14C 1, RW 1, S-3MEF 1, S-8 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-30 | 16:10 ET | [8-K](/filings/0001104659-26-120669.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001104659-26-120669 |
| 2026-08-14 | 16:17 ET | [10-Q](/filings/0001104659-26-097188.md) | Quarterly report, period 2026-06-30 | 0001104659-26-097188 |
| 2026-07-31 | 17:17 ET | [8-K](/filings/0001104659-26-089293.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001104659-26-089293 |
| 2026-07-20 | 19:48 ET | [8-K](/filings/0001104659-26-084743.md) | 7.01 Regulation FD disclosure | 0001104659-26-084743 |
| 2026-05-15 | 16:34 ET | [10-Q](/filings/0001104659-26-062661.md) | Quarterly report, period 2026-03-31 | 0001104659-26-062661 |
| 2026-04-15 | 16:16 ET | [10-K](/filings/0001104659-26-043806.md) | Annual report, period 2025-12-31 | 0001104659-26-043806 |
| 2026-04-07 | 12:30 ET | [8-K](/filings/0001104659-26-040260.md) | 2.01 Completion of an acquisition or disposition | 0001104659-26-040260 |
| 2026-01-15 | 17:06 ET | [8-K](/filings/0001104659-26-004146.md) | 8.01 Other events | 0001104659-26-004146 |
| 2026-01-02 | 17:14 ET | [8-K](/filings/0001104659-26-000243.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-000243 |
| 2025-11-28 | 16:43 ET | [DEF 14A](/filings/0001104659-25-116966.md) | Proxy statement, period 2025-12-29 | 0001104659-25-116966 |
| 2025-11-20 | 16:26 ET | [8-K](/filings/0001104659-25-114627.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001104659-25-114627 |
| 2025-11-14 | 16:44 ET | [10-Q](/filings/0001104659-25-112676.md) | Quarterly report, period 2025-09-30 | 0001104659-25-112676 |
| 2025-10-31 | 12:29 ET | [8-K](/filings/0001104659-25-104812.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001104659-25-104812 |
| 2025-10-30 | 16:40 ET | [8-K](/filings/0001104659-25-104427.md) | 1.01 Entry into a material agreement | 0001104659-25-104427 |
| 2025-10-24 | 12:28 ET | [8-K](/filings/0001104659-25-102049.md) | 8.01 Other events | 0001104659-25-102049 |
| 2025-10-14 | 14:22 ET | [8-K](/filings/0001104659-25-099196.md) | 8.01 Other events | 0001104659-25-099196 |
| 2025-08-14 | 17:00 ET | [10-Q](/filings/0001410578-25-001825.md) | Quarterly report, period 2025-06-30 | 0001410578-25-001825 |
| 2025-05-15 | 16:23 ET | [10-Q](/filings/0001410578-25-001333.md) | Quarterly report, period 2025-03-31 | 0001410578-25-001333 |
| 2025-03-31 | 17:23 ET | [10-K](/filings/0001410578-25-000598.md) | Annual report, period 2024-12-31 | 0001410578-25-000598 |
| 2024-12-26 | 16:29 ET | [8-K](/filings/0001104659-24-131723.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-24-131723 |
| 2024-11-12 | 16:10 ET | [10-Q](/filings/0001410578-24-001879.md) | Quarterly report, period 2024-09-30 | 0001410578-24-001879 |
| 2024-11-01 | 17:24 ET | [8-K](/filings/0001104659-24-113553.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001104659-24-113553 |
| 2024-08-09 | 17:06 ET | [10-Q](/filings/0001410578-24-001278.md) | Quarterly report, period 2024-06-30 | 0001410578-24-001278 |
| 2024-08-02 | 10:42 ET | [8-K](/filings/0001104659-24-085198.md) | 7.01 Regulation FD disclosure | 0001104659-24-085198 |
| 2024-07-03 | 14:44 ET | [8-K](/filings/0001104659-24-077718.md) | 5.07 Shareholder vote results | 0001104659-24-077718 |
| 2024-06-04 | 17:11 ET | [8-K](/filings/0001104659-24-068314.md) | 1.01 Entry into a material agreement | 0001104659-24-068314 |
| 2024-06-03 | 17:22 ET | [DEF 14A](/filings/0001104659-24-067885.md) | Proxy statement, period 2024-06-29 | 0001104659-24-067885 |
| 2024-05-10 | 17:04 ET | [10-Q](/filings/0001410578-24-000741.md) | Quarterly report, period 2024-03-31 | 0001410578-24-000741 |
| 2024-05-02 | 16:39 ET | [8-K](/filings/0001104659-24-056424.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001104659-24-056424 |
| 2024-04-29 | 17:03 ET | [10-K/A](/filings/0001104659-24-054153.md) | Annual report, amended, period 2023-12-31 | 0001104659-24-054153 |
| 2024-03-22 | 16:30 ET | [8-K](/filings/0001104659-24-037901.md) | 5.02 Departure or appointment of officers or directors | 0001104659-24-037901 |
| 2024-03-14 | 16:30 ET | [8-K](/filings/0001104659-24-034527.md) | 5.02 Departure or appointment of officers or directors | 0001104659-24-034527 |
| 2024-03-05 | 17:14 ET | [10-K](/filings/0001410578-24-000133.md) | Annual report, period 2023-12-31 | 0001410578-24-000133 |
| 2023-11-16 | 17:11 ET | [8-K](/filings/0001104659-23-119165.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001104659-23-119165 |
| 2023-11-09 | 16:30 ET | [10-Q](/filings/0001410578-23-002304.md) | Quarterly report, period 2023-09-30 | 0001410578-23-002304 |
| 2023-08-09 | 16:36 ET | [10-Q](/filings/0001410578-23-001633.md) | Quarterly report, period 2023-06-30 | 0001410578-23-001633 |
| 2023-05-10 | 16:33 ET | [10-Q](/filings/0001410578-23-000976.md) | Quarterly report, period 2023-03-31 | 0001410578-23-000976 |
| 2023-03-08 | 16:56 ET | [8-K](/filings/0001104659-23-030141.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001104659-23-030141 |
| 2023-02-28 | 16:27 ET | [10-K](/filings/0001410578-23-000185.md) | Annual report, period 2022-12-31 | 0001410578-23-000185 |
| 2023-01-13 | 16:34 ET | [8-K](/filings/0001104659-23-003846.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-23-003846 |
| 2023-01-06 | 16:41 ET | [8-K](/filings/0001104659-23-001886.md) | 5.07 Shareholder vote results | 0001104659-23-001886 |
| 2022-12-05 | 07:00 ET | [DEF 14A](/filings/0001104659-22-124360.md) | Proxy statement, period 2022-12-30 | 0001104659-22-124360 |
| 2022-11-09 | 16:27 ET | [10-Q](/filings/0001410578-22-003073.md) | Quarterly report, period 2022-09-30 | 0001410578-22-003073 |
| 2022-08-09 | 16:12 ET | [10-Q](/filings/0001410578-22-002177.md) | Quarterly report, period 2022-06-30 | 0001410578-22-002177 |
| 2022-07-26 | 16:47 ET | [8-K](/filings/0001104659-22-082813.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-22-082813 |
| 2022-06-30 | 17:08 ET | [10-K/A](/filings/0001104659-22-076361.md) | Annual report, amended, period 2021-12-31 | 0001104659-22-076361 |
| 2022-05-10 | 17:58 ET | [10-Q](/filings/0001410578-22-001218.md) | Quarterly report, period 2022-03-31 | 0001410578-22-001218 |
| 2022-05-02 | 17:03 ET | [10-K/A](/filings/0001104659-22-054757.md) | Annual report, amended, period 2021-12-31 | 0001104659-22-054757 |
| 2022-03-01 | 12:48 ET | [10-K](/filings/0001410578-22-000244.md) | Annual report, period 2021-12-31 | 0001410578-22-000244 |
| 2021-11-29 | 16:29 ET | [8-K](/filings/0001104659-21-144456.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001104659-21-144456 |

Page 1 of 7. [Older](/companies/nwbo/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 16:18 ET. No prices; not investment advice.